NASH

To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects

Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease

Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease

Detecting Liver Fibrosis in Patients At-risk

Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease

Assessment of Fatty Liver With Thermo-acoustic Device

Early Liver Disease Breath Detection

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Digoxin In NASH (CODIN)

Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver Disease

A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Androgens and NAFLD Longitudinal Cohort Study

RE and Probiotics in MAFLD/NAFLD

Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)

A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients

A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH

An Imaging-based Quantitative Biomarker Assay for NAFLD in Children